XXXX in @entity1358 : @entity6715 .

@entity1 @entity5517 @entity267 @entity6715 @entity1036 @entity2348 @entity1358 @entity22939 @entity288
PURPOSE: To investigate the incidence, clinical and microbiological characteristics, risk factors, and therapeutic outcome of @entity1036 in @entity1 with @entity1358 ( @entity1358 ) related to @entity6715 ( @entity6715 ) and corneal chemical burn. METHODS: Medical records of 90 eyes of 59 @entity1 who were diagnosed with @entity1358 resulting from @entity6715 (52 eyes of 29 @entity1 ) or corneal chemical burn (38 eyes of 30 @entity1 ) were reviewed. RESULTS: @entity1036 developed in 35% of @entity1358 @entity1 with @entity6715 (18 eyes, 14 @entity1 ) and in 18% of those with chemical burn (7 eyes, 7 @entity1 ). The development of @entity1036 in @entity6715 was significantly associated with the severity of chronic ocular surface complications in the @entity267 , conjunctiva, and eyelids and with the use of topical @entity288 during the disease course. All cases of @entity1036 following chemical burn occurred in @entity1 with grade III or IV burn by Roper-Hall classification. Approximately 83% of culture-proven cases of @entity1036 were @entity2348 , most of which (80%) were caused by Gram-positive bacteria. For resolution of @entity5517 (68%) received surgery in addition to medical treatment, whereas 8 eyes (32%) received medical treatment alone. After infection resolution, the final visual acuity was decreased in 10 eyes (40%) compared with before infection. CONCLUSIONS: @entity1036 is a common complication of @entity1358 associated with @entity6715 or severe @entity22939 . Despite medical and surgical treatments, the visual outcome is poor.
